Follow
Kseniia Suska, Ксенія Суська, Ксения Суская
Kseniia Suska, Ксенія Суська, Ксения Суская
Державний заклад "Дніпропетровська медична академія Міністерства охорони здоров`я України"
Verified email at dsma.dp.ua
Title
Cited by
Cited by
Year
Microbiome landscape and disease duration role in allergy in adult patients with bronchiectasis
K Gashynova, K Suska, V Dmytrychenko
European Respiratory Journal 54 (s. 63), PA2763, 2019
62019
Bronchoectatic disease: the state of art and the clinical case.
TO Pertseva, KY Gashynova, VV Dmytrychenko, KS Suska
Medicni perspektivi 23 (3 (part1)), 153-161, 2018
42018
Factors affecting the frequency of exacerbations in adult patients with bronchiectasis
K Gashynova, K Suska, V Dmytrychenko
Wiad Lek 73 (8), 1717-1722, 2020
32020
Бронхоектатична хвороба: сучасний стан проблеми та клінічний випадок
ТО Перцева, КЮ Гашинова, ВВ Дмитриченко, КС Суська
Медичні перспективи 23 (3-1), 153-161, 2018
32018
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
K Suska, F Amati, G Sotgiu, A Gramegna, M Mantero, M Ori, M Ferrarese, ...
ERJ Open Research 8 (4), 2022
22022
Peripheral blood eosinophilia and sensitization to Aspergillus fumigatus in adult patients (pts) with non-cystic fibrosis bronchiectasis (B)
K Gashynova, V Dmytrychenko, K Suska
European Respiratory Journal 5 (s. 63), 2019
22019
The perspective of clinical pharmacologist: what is the safety of complex polypharmacy in hospitalized COVID-19 patients?
O Kovalenko, V Rudakova, K Suska, K Gashynova, N But
European Respiratory Journal 60 (suppl 66), 2022
12022
Regional features of Pseudomonas aeruginosa (PA) antibiotic (AB) resistance (R) in patients (pts) with bronchiectasis (Bx)
K Suska, K Gashynova, V Dmytrychenko
European Respiratory Journal 60 (suppl 66), 2022
12022
Etiology of Bronchiectasis in Adults in Ukraine
K Suska, K Gashynova, V Dmytrychenko
European Respiratory Journal 60 (suppl 66), 2022
12022
The prevalence of primary ciliary dyskinesia (PCD) in adult patients with bronchiectasis in Dnipro (Ukraine)
K Suska, K Gashynova, V Dmytrychenko
European Respiratory Journal 58 (suppl 65), 2021
12021
OVERWEIGHT PATIENTS WITH BRONCHIECTASIS: DOES IT MATTER FOR SPUTUM CULTURE?
K Suska, K Gashynova, V Dmytrychenko
Chest 158 (4), A345, 2020
12020
LSC-2020-Could the overweight influence bronchiectasis (B) exacerbations frequency (EF)?
K Suska, K Gashynova, V Dmytrychenko
European Respiratory Journal 56 (suppl 64), 2020
12020
Use of Decametoxinum in bronchiectasis
K Gashynova, K Suska, V Dmytrychenko
European Respiratory Journal 56 (suppl 64), 2020
12020
Determination of the effectiveness of short-term nebulizer therapy in bronchiectasis
KY Gashynova, KS Suska, VV Dmytrychenko
Infusion & Chemotherapy, 21-28, 2022
2022
A Retrospective Single-Center Analysis of COVID-19 Patients with Fatal Outcome
K Gashynova, N But, V Rudakova, K Suska, V Dmytrychenko
C62. EXPANDING OUR INSIGHT INTO COVID-19, A4586-A4586, 2022
2022
Primary Ciliary Dyskinesia Diagnosis by the Measurement Nasal Nitric Oxide Level in Adults with Bronchiectasis in Ukraine
K Suska, K Gashynova
A40. INVESTIGATIONS IN CYSTIC FIBROSIS AND NON-CF BRONCHIECTASIS, A1468-A1468, 2022
2022
Anti-aspergillus fumigatus immunity in patients with bronchiectasis in Ukraine: which test is better?
K Gashynova, K Suska, V Dmytrychenko
ALLERGY 76, 74-74, 2021
2021
The Effectiveness of Decametoxinum Inhalations in Patients with Bronchiectasis
K Gashynova, K Suska, V Dmytrychenko
TP96. TP096 CLINICAL AND BASIC SCIENCE DEVELOPMENTS IN NTM AND …, 2021
2021
Specific Asthmatic Phenotype of Patients with Bronchiectasis in Ukraine
K Suska, K Gashynova, V Dmytrychenko
TP32. TP032 EPIDEMIOLOGY, BIOMARKERS, AND THERAPY IN CF AND NON-CF …, 2021
2021
ERS International Congress 2020: highlights from the Respiratory Infections assembly
S Frent, C Calarasu, K Suska, K Gashynova, H Keir
ERJ Open Research 7 (2), 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20